We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+30.5%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$397M
AUM Growth
+$139M
Cap. Flow
+$84.8M
Cap. Flow %
21.35%
Top 10 Hldgs %
59.44%
Holding
33
New
7
Increased
12
Reduced
2
Closed
9

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$24.5M
2
BAX icon
Baxter International
BAX
+$20M
3
IQV icon
IQVIA
IQV
+$18.6M
4
EHC icon
Encompass Health
EHC
+$10.2M
5
GH icon
Guardant Health
GH
+$10.1M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$12.6M
2
COR icon
Cencora
COR
+$9.73M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$8.98M
4
HCA icon
HCA Healthcare
HCA
+$7.19M
5
ISRG icon
Intuitive Surgical
ISRG
+$6.93M

Sector Composition

Rank Sector Weight
1 Healthcare 90.25%
2 Technology 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COR icon
26
Cencora
COR
$60.5B
– –
-110,000
Closed -$9.73M
DXCM icon
27
DexCom
DXCM
$28.3B
– –
-80,000
Closed -$5.38M
HCA icon
28
HCA Healthcare
HCA
$86.4B
– –
-80,000
Closed -$7.19M
HRTX icon
29
Heron Therapeutics
HRTX
$86.9M
– –
-500,000
Closed -$5.87M
HUM icon
30
Humana
HUM
$45.8B
– –
-40,000
Closed -$12.6M
ISRG icon
31
Intuitive Surgical
ISRG
$128B
– –
-42,000
Closed -$6.93M
SDGR icon
32
Schrodinger
SDGR
$1.14B
– –
-150,000
Closed -$6.47M
TEVA icon
33
Teva Pharmaceuticals
TEVA
$36.2B
– –
-1,000,000
Closed -$8.98M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Iron Triangle Partners held 33 positions worth $397M, up 54% from $259M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Iron Triangle Partners deployed $84.8M of net new capital in Q2 2020, opening 7 new positions and adding to 12 existing holdings. Its largest new stake was Hologic: 500,000 shares worth $28.5M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 93% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $2.73M trimmed.

  • Iron Triangle Partners's largest Q2 2020 buy was Hologic: 500,000 shares worth $28.5M.
  • Iron Triangle Partners added most to Baxter International in Q2 2020, an estimated $20M increase.
  • Iron Triangle Partners's biggest Q2 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $2.73M.
  • Iron Triangle Partners fully exited Humana in Q2 2020, selling an estimated $12.6M.
  • Iron Triangle Partners's ten largest holdings make up 59% of its $397M portfolio in Q2 2020.
  • Iron Triangle Partners opened 7 new positions and closed 9 in Q2 2020.
  • Iron Triangle Partners's portfolio value rose 54% quarter-over-quarter to $397M.

Based on Iron Triangle Partners's 13F filing for Q2 2020, filed 14 Aug 2020.